EMA advice on the use of NSAIDs for Covid-19

Drug Ther Bull. 2020 May;58(5):69. doi: 10.1136/dtb.2020.000021. Epub 2020 Mar 31.

Abstract

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.

Keywords: Health Care Quality, Access, and Evaluation; Primary Health Care.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal* / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal* / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Europe
  • Humans
  • Ibuprofen / adverse effects
  • Ibuprofen / therapeutic use
  • International Agencies
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ibuprofen

Supplementary concepts

  • COVID-19 drug treatment